BHMS Investments, LP, through affiliated funds, completed the acquisition of Osmotics Corporation , a boutique producer of science-based anti-aging skincare products. Osmotics is an industry leader in the advanced skincare market or cosmeceuticals, which it helped pioneer upon its founding in 1993. The BHMS acquisition will be accompanied by a growth equity investment.
Francine Porter, the Company’s Founder, will continue to lead the Company as Chief Executive Officer. Mrs. Porter said, “In BHMS, we have found the partner that will best enable us to continue to capitalize on the strong brand that is Osmotics as well as enhance our presence.”
Robert Salamon, Managing Partner at BHMS, said, “BHMS is excited to support an outstanding team and a brand that has withstood the test of time. Osmotics has continuously provided superior quality, efficacy and innovation resulting in a highly devoted customer base.”
Osmotics is a boutique producer of science-based anti-aging skincare products. The Company’s award winning, innovative products continue to advance the science and art of cosmeceuticals. Osmotics products are primarily sold in the domestic market via specialty department stores, independent boutiques and on the Company’s website. The Company is based in Denver, Colorado and additional information can be found at www.osmotics.com.
BHMS Investments, LP is a private investment firm focused on the North American middle market. The firm was founded in 2010 and is based in New York City. BHMS invests in a wide variety of control opportunities from acquiring companies in financial distress to conventional leveraged buyouts. The BHMS mandate and Partner experience includes investing across all sectors of the economy. Additional information can be found at www.bhmsinvestments.com.